KalVista Pharmaceuticals
KALV
KALV
48 hedge funds and large institutions have $278M invested in KalVista Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 3 closing their positions.
Holders
48
Holders Change
+22
Holders Change %
+84.62%
% of All Funds
1.1%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.09%
New
25
Increased
9
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
VMI
1
VHCP Management III
New York
|
$28.4M |
2 |
VC
2
Vivo Capital
Palo Alto,
California
|
$30.1M |
3 |
VMI
3
VHCP Management II
New York
|
$16.8M |
4 |
DM
4
Deerfield Management
New York
|
$14.4M |
5 |
BI
5
BVF Inc
San Francisco,
California
|
$13.5M |